COVID-19, Hydroxychloroquine, and the Death of Evidence-Based Medicine (Its working-The Medical Deepstate is denying it)

An E.R. Doctor Infected With Covid-19 Back At Work After Using ...

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

FROM NATURE.COM ! < — So why won’t the Main Stream Media report on this? 

Wang, M., Cao, R., Zhang, L. et al. Remdesivir and chloroquine – “Our findings reveal that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro. Since these compounds have been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease.”

An NY E.R. Doctor Infected With Covid-19 Back At Work After Using Hydroxychloroquine and Z-Pak Protocol

Dr. Ban G. Truong, DO, PhD, FACEP, ABAARM

Dr. Ban is a physician with a PhD in Nutrition, and who is quadruple board certified in Emergency Medicine, Obesity Medicine, Anti-Aging and Regenerative Medicine, and as a Physician Nutrition Specialist. In addition to having practiced in several large, urban emergency departments throughout the country, he also served as a Life Flight doctor treating patients in the field and supporting them as they are transported between medical facilities.

Hydroxychloroquine is saving lives NOW! Daughter saves her father ...

He owns and operates several brick-and-mortar clinics that range from primary care to urgent care. He also owns and operates a telemedicine clinic. Dr. Ban serves as the Medical Director for Weightless4Life, a role that he approaches with the thoughtfulness and compassion gained from years regularly seeing patients in the primary, urgent, and emergency settings. Dr. Ban was also a college professor who taught nutrition and the sciences. As such, he believes in the power of education through the dissemination of quality information.

As the world became affected by COVID-19, Dr. Ban began to share information about the pandemic based on his broad and vast experience treating patients and his research background and understanding of proper research protocols.

From ABC 7 Los Angeles  

LA doctor seeing success with hydroxychloroquine to treat COVID-19 ...

A Los Angeles doctor said he is seeing significant success in prescribing the malaria drug hydroxychloroquine in combination with zinc to treat patients with severe symptoms of COVID-19.

See:

Remdesivir has been recently recognized as a promising antiviral drug against a wide array of RNA viruses (including SARS/MERS-CoV5) infection in cultured cells, mice and nonhuman primate (NHP) models. It is currently under clinical development for the treatment of Ebola virus infection.6 Remdesivir is an adenosine analogue, which incorporates into nascent viral RNA chains and results in pre-mature termination.7 Our time-of-addition assay showed remdesivir functioned at a stage post virus entry (Fig. 1c, d), which is in agreement with its putative anti-viral mechanism as a nucleotide analogue. Warren et al. showed that in NHP model, intravenous administration of 10 mg/kg dose of remdesivir resulted in concomitant persistent levels of its active form in the blood (10 μM) and conferred 100% protection against Ebola virus infection.7 Our data showed that EC90 value of remdesivir against 2019-nCoV in Vero E6 cells was 1.76 μM, suggesting its working concentration is likely to be achieved in NHP. Our preliminary data (Supplementary information, Fig. S2) showed that remdesivir also inhibited virus infection efficiently in a human cell line (human liver cancer Huh-7 cells), which is sensitive to 2019-nCoV.2

Chloroquine, a widely-used anti-malarial and autoimmune disease drug, has recently been reported as a potential broad-spectrum antiviral drug.8,9 Chloroquine is known to block virus infection by increasing endosomal pH required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of SARS-CoV.10 Our time-of-addition assay demonstrated that chloroquine functioned at both entry, and at post-entry stages of the 2019-nCoV infection in Vero E6 cells (Fig. 1c, d). Besides its antiviral activity, chloroquine has an immune-modulating activity, which may synergistically enhance its antiviral effect in vivo. Chloroquine is widely distributed in the whole body, including lung, after oral administration. The EC90 value of chloroquine against the 2019-nCoV in Vero E6 cells was 6.90 μM, which can be clinically achievable as demonstrated in the plasma of rheumatoid arthritis patients who received 500 mg administration.11 Chloroquine is a cheap and a safe drug that has been used for more than 70 years and, therefore, it is potentially clinically applicable against the 2019-nCoV.

Our findings reveal that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro. Since these compounds have been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease.

Wang, M., Cao, R., Zhang, L. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30, 269–271 (2020). https://doi.org/10.1038/s41422-020-0282-0

Download citation

So why won’t the Main Stream Media report on this?

We Need Your Support Please even A $1.00 donation will help keep Uncensored Independent Media and Our Free Press going.

Please CLICK ME AND DONATE VIA PAYPAL – THANK YOU!

TheWatchTowers.org
Translate »